Key result
First-time catheter ablation shows ~53% AF/AFL recurrence over long-term follow-up.
Why the study?
Data on atrial fibrillation or flutter recurrence over long-term follow-up after catheter ablation of AF were limited.
Over half of patients undergoing first-time AF ablation experience recurrence over long-term follow-up (average 6.1 years), with early recurrence, female sex, and left atrial structural changes being key predictors.
AF ablation recurrence warrants cautious long-term counseling; extends prior observational data but leaves optimal strategies open.
Background Data on atrial fibrillation (AF)/flutter (AFL) recurrence over long‐term follow‐up after catheter ablation of AF are limited. Objective Assess the rate, predictors, and temporal trends of long‐term post‐ablation AF/AFL recurrence. Methods We analyzed consecutive first‐time AF catheter ablations between 2008 and 2022 at our center who were captured in our AF ablation registry and outcomes data were supplemented with chart review. Multivariable predictors of any clinically documented AF/AFL after 3‐month blanking period were identified with a stepwise‐selection multivariable proportional‐hazards model in randomly selected 70% data set and validated in remaining 30%. Results Among 2905 patients who underwent AF ablation (age 62.9 ± 10.5 years; female 30.5%; persistent 43.6%, long‐standing persistent 6.9%; primarily radiofrequency, cryoballoon 18.0%), within 2 years 38.0% had recurrence, and over average 6.1 ± 4.4‐years follow‐up 53.2% recurred. Multivariable predictors of recurrence (all p < 0.02) included recurrence during blanking period (HR 2.42, 95% CI 2.13–2.74), female sex (1.39, 1.22–1.59), each centimeter increase in LA size (1.34, 1.21–1.49), maximum regional LA fibrosis moderate (1.46, 1.25–1.71) or severe (1.42, 1.14–1.78), every year of AF duration (1.02, 1.00–1.03), and persistent (1.19, 1.03–1.37) or long‐standing persistent AF (1.40, 1.10–1.78). Increasing quartiles of risk in the validation set had higher recurrences (compared to Q1; Q2 1.62, 1.19‐2.19; Q3 2.58, 1.92–3.46; Q4 4.60, 3.46–6.11; all p < 0.0001). Conclusion Over an average 6.1‐year follow‐up, over half of AF ablation patients had a recurrence of AF/AFL. Independent predictors of recurrence were early recurrence during 3‐month blanking period, female sex, increased LA size, moderate/severe maximum regional LA fibrosis, longer AF duration, and non‐paroxysmal AF. CONDENSED ABSTRACT This observational single‐center evaluation included 2905 consecutive AF first‐time catheter ablation patients between 2008 and 2022 (age 62.9 ± 10.5 years; female 30.5%; persistent 43.6%, long‐standing persistent 6.9%; mostly radiofrequency, cryoballoon 18.0%; follow‐up 6.1 ± 4.4 years). A multivariable model developed in 70% data set predicted late (> 3 months) AF/flutter recurrences in remaining 30%. Predictors included recurrence during blanking period (HR 2.42, 95% CI 2.13–2.74), female sex (1.39, 1.22–1.59), each cm increase in LA size (1.34, 1.21–1.49), maximum regional LA fibrosis moderate (1.46, 1.25–1.71) or severe (1.42, 1.14–1.78), every year of AF duration (1.02, 1.00–1.03), and persistent (1.19, 1.03–1.37) or long‐standing persistent AF (1.40, 1.10–1.78).
No takes yet. Share an insight, caveat, or question.
Cushing et al. (2026) studied this question. Over an average follow-up of 6.1 years, 53.2% of patients experienced AF/AFL recurrence after catheter ablation, with several independent predictors identified.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: